AU2001291904C1 - Liposomes encapsulating anticancer drugs and the use thereof in the treatment of malignant tumors - Google Patents

Liposomes encapsulating anticancer drugs and the use thereof in the treatment of malignant tumors

Info

Publication number
AU2001291904C1
AU2001291904C1 AU2001291904A AU2001291904A AU2001291904C1 AU 2001291904 C1 AU2001291904 C1 AU 2001291904C1 AU 2001291904 A AU2001291904 A AU 2001291904A AU 2001291904 A AU2001291904 A AU 2001291904A AU 2001291904 C1 AU2001291904 C1 AU 2001291904C1
Authority
AU
Australia
Prior art keywords
treatment
malignant tumors
anticancer drugs
liposomes encapsulating
encapsulating anticancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2001291904A
Other versions
AU2001291904B2 (en
AU2001291904A1 (en
Inventor
Angels Fabra Fres
Josep Garces Garces
Antonio Parente Duena
Maria Dolores Polo Trasancos
Ferran Pons Lambiez
Francesca Reig Isart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GP Pharm SA
Original Assignee
GP Pharm SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES200002447A external-priority patent/ES2186484B1/en
Application filed by GP Pharm SA filed Critical GP Pharm SA
Publication of AU2001291904A1 publication Critical patent/AU2001291904A1/en
Application granted granted Critical
Publication of AU2001291904B2 publication Critical patent/AU2001291904B2/en
Publication of AU2001291904C1 publication Critical patent/AU2001291904C1/en
Assigned to GP PHARM, S.A. reassignment GP PHARM, S.A. Request for Assignment Assignors: LIPOTEC, S.A.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001291904A 2000-10-10 2001-10-03 Liposomes encapsulating anticancer drugs and the use thereof in the treatment of malignant tumors Ceased AU2001291904C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP200002447 2000-10-10
ES200002447A ES2186484B1 (en) 2000-10-10 2000-10-10 LIPOSOMES ENCAPSULATING ANTI-CANCER DRUGS AND USE OF THEM IN THE TREATMENT OF EVIL TUMORS.
PCT/ES2001/000367 WO2002030397A1 (en) 2000-10-10 2001-10-03 Liposomes encapsulating anticancer drugs and the use thereof in the treatment of malignant tumors

Publications (3)

Publication Number Publication Date
AU2001291904A1 AU2001291904A1 (en) 2002-06-27
AU2001291904B2 AU2001291904B2 (en) 2006-05-11
AU2001291904C1 true AU2001291904C1 (en) 2007-03-08

Family

ID=

Similar Documents

Publication Publication Date Title
PL354540A1 (en) Drugs for the treatment of malignant tumours
GB9903841D0 (en) Diagnosis and treatment of cancer
HUP0203238A3 (en) Drugs for the treatment of malignant tumours, process for their preparation and pharmaceutical compositions containing them
IL157993A0 (en) Molecular conjugates for use in cancer treatment and methods for the preparation thereof
HK1045462A1 (en) Combined preparations comprising morpholine anthracyclines and anticancer agent
HUP0004326A3 (en) Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
AU2001294834A1 (en) Recombinant bcg vaccines for the prevention and treatment of cancer
AU4373499A (en) Use of drug-loaded nanoparticles for the treatment of cancers
AU2001245295A1 (en) Methods and compositions for the identification, assessment, prevention and therapy of human cancers
HUP0100350A3 (en) Conjugates useful in the treatment of prostate cancer, pharmaceutical compositions comprising thereof, process for their preparation and their use
AU6814601A (en) Use of mutant herpes viruses and anticancer agents in the treatment of cancer
AU2001243349A1 (en) Methods for the diagnosis and treatment of breast cancer
AU2002243363A1 (en) Use of aziridino-compounds in the treatment of immune dysfunctions
AU2001238493A1 (en) Methods and compositions for the identification, assessment, prevention and therapy of human cancers
AU4369800A (en) Treatment of metastatic cancer through mts-1 gene
WO2002034244A3 (en) A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
AU2001291904C1 (en) Liposomes encapsulating anticancer drugs and the use thereof in the treatment of malignant tumors
AU2001291904A1 (en) Liposomes encapsulating anticancer drugs and the use thereof in the treatment of malignant tumors
AU4281200A (en) Immuno-adjuvant pdt treatment of metastatic tumors
AU2001276462A1 (en) Use of natural products in cancer treatment
AU2002215111A1 (en) Ruthenium-aryl-compounds in cancer therapy
AU6111800A (en) 26 human prostate and prostate cancer associated proteins
AU2002346049A1 (en) Coactivators in the diagnosis and treatment of breast cancer
ZA984650B (en) Intratumoral administration of triphenylethylenes for the treatment of cancer
IL132531A0 (en) Detection and therapy of tumors